Article
Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model
7 Aug 2014
Abstract excerpt
X-linked agammaglobulinemia (XLA) is an inherited immunodeficiency that results from mutations within the gene encoding Bruton's tyrosine kinase (BTK). Many XLA-associated mutations affect splicing of BTK pre-mRNA and severely impair B cell development. Here, we assessed the potential of antisense, splice-correcting oligonucleotides (SCOs) targeting mutated BTK transcripts for treating XLA. Both the SCO...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
